From filing to price impact: microstructure, currency-normalised comparisons, walk-forward design.
HSBC is riding buybacks, stronger NII guidance and a bank rally. The catch is valuation, execution and what the insider record does not show.
Tezspire data, a €2.55bn bond and a mixed oncology week keep AstraZeneca in focus as the sector trades on trial wins and funding discipline.
Aurizon directors bought again as coal, bulk and buybacks reset the rail story. Here is how the filings stack up against Union Pacific.
Credit Corp directors bought into August weakness after record FY26 profit. The cluster helps, but US debt-buying conditions and cohort math matter.
Vimian’s CEO and two executives bought shares on August 29 as the stock traded near SEK 35.50, with animal health still drawing defensive flows.
Mitie directors bought after the OCS bid and a break above the 200-day average. Here is how the filings look beside Serco and ISS.
Rahul Mohta bought HCL Technologies shares as IT rallied on Nvidia-led optimism. The cluster helps, but the macro and cohort math still matter.
Two Reckitt directors bought shares on 26 August as staples lagged peers, buybacks continued and the stock sat near the middle of its 52-week range.
Sharon Brown bought 10,000 Personal Assets Trust shares for GBP 55,584.68. Read the cluster, the buyback, and the trust's defensive positioning.
Bonesupport insiders kept buying in late August while the stock traded near 70x earnings. We read the cluster against orthobiologics peers and macro.
OVH Groupe’s August 28 insider sale lands after a 13% slide and a CFO shake-up, with AI cloud demand still doing the heavy lifting.
M&S directors bought 77 shares via the SIP as UK retail stays soft. Here is what the filing adds, and where the case still frays.